title: Beneficial effect of quinapril in patients with angiotensin-converting enzyme D allele after coronary stenting.
authors.forename: K
authors.initials: K
authors.lastname: Okumura
authors.forename: H
authors.initials: H
authors.lastname: Kamiya
authors.forename: H
authors.initials: H
authors.lastname: Matsui
authors.forename: T
authors.initials: T
authors.lastname: Sone
authors.forename: J
authors.initials: J
authors.lastname: Kondo
authors.forename: H
authors.initials: H
authors.lastname: Tsuboi
authors.forename: H
authors.initials: H
authors.lastname: Mukawa
mesh_terms: D000483:Alleles; D017130:Angioplasty; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D023921:Coronary Stenosis / Q000188:drug therapy* / Q000235:genetics / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007546:Isoquinolines / Q000627:therapeutic use*; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D011336:Probability; D000077583:Quinapril; D055502:Secondary Prevention; D012680:Sensitivity and Specificity; D015607:Stents; D044005:Tetrahydroisoquinolines; D016896:Treatment Outcome
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril